Explore
Validate
LearnABIN446462
antibody from antibodies-online
Targeting: CCL2
GDCF-2, HC11, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF
Western blot
Immunocytochemistry
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN446462 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Chemokine (C-C Motif) Ligand 2 (CCL2) (AA 15-40), (Internal Region) antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified
- Reactivity
- Human, Rat
- Host
- Rabbit
- Epitope
- AA 15-40, Internal Region
- Vial size
- 0.1 mL
- Storage
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
- Handling
- Avoid freeze-thaw cycles
Submitted references The anti-ALS drug riluzole attenuates pericyte loss in the diabetic retinopathy of streptozotocin-treated mice.
SIRT1 inhibition promotes atherosclerosis through impaired autophagy.
Infection with Mycobacterium avium subsp. paratuberculosis results in rapid interleukin-1β release and macrophage transepithelial migration.
Reduction of activated macrophages after ischaemia-reperfusion injury diminishes oxidative stress and ameliorates renal damage.
Choi JA, Chung YR, Byun HR, Park H, Koh JY, Yoon YH
Toxicology and applied pharmacology 2017 Jan 15;315:80-89
Toxicology and applied pharmacology 2017 Jan 15;315:80-89
SIRT1 inhibition promotes atherosclerosis through impaired autophagy.
Yang X, Wei J, He Y, Jing T, Li Y, Xiao Y, Wang B, Wang W, Zhang J, Lin R
Oncotarget 2017 Aug 1;8(31):51447-51461
Oncotarget 2017 Aug 1;8(31):51447-51461
Infection with Mycobacterium avium subsp. paratuberculosis results in rapid interleukin-1β release and macrophage transepithelial migration.
Lamont EA, O'Grady SM, Davis WC, Eckstein T, Sreevatsan S
Infection and immunity 2012 Sep;80(9):3225-35
Infection and immunity 2012 Sep;80(9):3225-35
Reduction of activated macrophages after ischaemia-reperfusion injury diminishes oxidative stress and ameliorates renal damage.
Fet NG, Fiebeler A, Klinge U, Park JK, Barth S, Thepen T, Tolba RH
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012 Aug;27(8):3149-55
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012 Aug;27(8):3149-55
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
